Medifast to Announce Financial Results for the First Quarter Ended March 31, 2023
Medifast (NYSE: MED) will report its financial results for Q1 2023, which ended on March 31, on May 1, 2023, after the market closes. This announcement will be followed by a conference call at 4:30 PM ET the same day, featuring Dan Chard, CEO, and Jim Maloney, CFO. The call will be accessible via the Investor Relations section of Medifast's website and archived until August 1, 2023. Medifast is a leader in the U.S. weight management industry, generating around $7 billion in revenue and known for its OPTAVIA brand that promotes healthy habits. The company has received recognition as one of America’s Best Mid-Sized Companies and has positively impacted over 2 million lives through its health and wellness community.
- Medifast is recognized as a leader in the $7 billion U.S. weight management industry.
- The company has positively impacted over 2 million lives through its community.
- None.
Insights
Analyzing...
The conference call is scheduled to begin at
A telephonic playback will be available from
About Medifast®:
MED-F
View original content to download multimedia:https://www.prnewswire.com/news-releases/medifast-to-announce-financial-results-for-the-first-quarter-ended-march-31-2023-301799178.html
SOURCE